These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 2140730
21. [Recent advances in hypoxic cell radiosensitizer]. Ono K, Takahashi M, Nishidai T, Shibamoto Y, Abe M. Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470 [Abstract] [Full Text] [Related]
22. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors. Ono K, Takahashi M, Nishidai T, Dodo Y, Shibamoto Y, Hiraoka M, Yukawa Y, Abe M. Radiat Med; 1984 Oct; 2(1):71-5. PubMed ID: 6242712 [Abstract] [Full Text] [Related]
24. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II). Herman TS, Teicher BA, Pfeffer MR, Khandekar V, Chapnick RM, Kalick GS, Rabow A. Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699 [Abstract] [Full Text] [Related]
25. Fluorinated 2-nitroimidazole derivative hypoxic cell radiosensitizers: radiosensitizing activities and pharmacokinetics. Sasai K, Iwai H, Yoshizawa T, Nishimoto S, Shibamoto Y, Oya N, Shibata T, Abe M. Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):579-82. PubMed ID: 8005818 [Abstract] [Full Text] [Related]
26. Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical use. Shibamoto Y, Sasai K, Sakaguchi M, Tamulevicius P, Kitakabu Y, Streffer C, Abe M. Int J Radiat Biol; 1991 Jan 15; 59(1):105-15. PubMed ID: 1671058 [Abstract] [Full Text] [Related]
27. The development of an oral prodrug, SR-2545, of the 2-nitroimidazole radiosensitizer SR-2508. Coleman CN, Lee WW, Constine LS, Brown JM. Int J Radiat Oncol Biol Phys; 1982 Jan 15; 8(3-4):431-4. PubMed ID: 6213588 [Abstract] [Full Text] [Related]
28. Characteristics of fluorinated nitroazoles as hypoxic cell radiosensitizers. Shibamoto Y, Nishimoto S, Shimokawa K, Hisanaga Y, Zhou L, Wang J, Sasai K, Takahashi M, Abe M, Kagiya T. Int J Radiat Oncol Biol Phys; 1989 Apr 15; 16(4):1045-8. PubMed ID: 2703384 [Abstract] [Full Text] [Related]
29. Pharmacokinetics and toxicology of continuously infused nitroimidazoles. Eifel PJ, Brown JM. Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1311-4. PubMed ID: 6236186 [Abstract] [Full Text] [Related]
30. Ocular absorption and toxicity of a radiosensitizer and its effect on hypoxic cells. Rootman J, Josephy PD, Adomat H, Palcic B. Arch Ophthalmol; 1982 Mar 15; 100(3):468-71. PubMed ID: 7199901 [Abstract] [Full Text] [Related]
31. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use. Brown JM, Yu NY, Brown DM, Lee WW. Int J Radiat Oncol Biol Phys; 1981 Jun 15; 7(6):695-703. PubMed ID: 6457018 [No Abstract] [Full Text] [Related]
39. Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides. Bonnet M, Hong CR, Wong WW, Liew LP, Shome A, Wang J, Gu Y, Stevenson RJ, Qi W, Anderson RF, Pruijn FB, Wilson WR, Jamieson SMF, Hicks KO, Hay MP. J Med Chem; 2018 Feb 08; 61(3):1241-1254. PubMed ID: 29253343 [Abstract] [Full Text] [Related]
40. In vitro hypoxic cytotoxicity of nitroimidazoles: uptake and cell cycle phase specificity. Sutherland RM, Keng P, Conroy PJ, McDermott D, Bareham BJ, Passalacqua W. Int J Radiat Oncol Biol Phys; 1982 Feb 08; 8(3-4):745-8. PubMed ID: 7107409 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]